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Hereditary pancreatitis is characterized by episodes of pancreatic inflammation 
accompanied by unrelenting abdominal pain, usually beginning in childhood.  Therefore, this 
emerging population of individuals is affected with a chronic pain condition affecting global 
quality of life.  A multidisciplinary approach, including psychosocial and behavioral factors, is 
necessary to elicit responses to and treat chronic pain.  Improving overall quality of life is an 
important outcome of interventions for chronic conditions.  Health-related quality of life reflects 
an individual’s physical and mental well-being.  This study documents the pain levels and 
quality of life of individuals with both hereditary and sporadic pancreatitis.  Data from 73 
individuals with hereditary pancreatitis and 271 individuals with sporadic pancreatitis who 
participated in the Hereditary Pancreatitis Study and the North American Pancreatitis Study 2 
were examined for this study.  The questionnaires addressed each subjects’ report of quality of 
life, severity and duration of pain, alcohol use, tobacco use, and diagnosis of diabetes.  Patient 
responses were analyzed using a battery of comparative analyses.  The SF-12® health survey was 
analyzed using an algorithm for standardizing and weighting the physical and mental health 
scores.  Pain and quality of life measures were compared to each other, as well as to several 
commonly measured environmental influences on health using correlation analysis, regression 
 iii 
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analysis, and the Mann-Whitney U test.  As hypothesized, individuals with familial pancreatitis 
reported worse pain and poorer overall quality of life than individuals with sporadic pancreatitis. 
Factors influencing the measure of pain include the duration, severity, frequency, and character. 
Other findings include correlations between (a) physical quality of life and gender, smoking, and 
alcohol, (b) pain and age, and (c) pain frequency and tobacco and alcohol use. This study will 
provide public health significance because the information can potentially assist health care 
professionals who work with individuals with pancreatitis and chronic pain, and who are 
assessing the necessity of psychosocial intervention or support services. 
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1.0  INTRODUCTION 
This investigation was undertaken to examine the factors influencing the perception of pain and 
the effect on quality of life in individuals with pancreatitis, with an eventual goal of identifying 
individuals who might benefit from involvement with a support group. Hereditary pancreatitis 
(HP) is an autosomal dominant condition characterized by acute episodes of pancreatic 
inflammation, which can progress to chronic pancreatitis. It is estimated that at least 1,000 
individuals in the United States are affected with hereditary pancreatitis.1 Most pancreatitis is 
caused by alcohol, gallstones, or unknown factors. However, hereditary pancreatitis is caused by 
an abnormal form of trypsin which often is activated in the pancreas.  Generally, individuals with 
a hereditary form of pancreatitis begin experiencing recurrent attacks in childhood.2 As a result, 
there is a population of individuals who are affected with a chronic pain condition that affects 
their general quality of life.  As with all genetic diseases, a hereditary pancreatitis predisposition 
has implications for other family members.  Therefore, these families also have to deal with 
issues such as the communication of genetic information to at-risk family members, the 
possibility of having transmitted the predisposition to children, and the guilt that may be 
associated with discovering that other family members also have an increased risk of 
pancreatitis, and subsequently pancreatic cancer.   
The features of pancreatitis are varied and include acute attacks of pain ranging from 
mild abdominal discomfort to life-threatening episodes of pancreatic necrosis and intractable 
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pain.3 A multidisciplinary approach comprised of psychosocial and behavioral factors that might 
influence the responses to chronic pain seems necessary in order to treat chronic pain 
successfully.4  Health-related quality of life is a multidimensional theoretical construct reflecting 
an individual’s global physical and mental well-being.5  The impact of chronic pain and its effect 
on emotional, physical and social functioning are addressed in quality of life surveys.  Improving 
overall quality of life is an important outcome of interventions, particularly for persons suffering 
from pain related to hereditary pancreatitis.  Support groups are one available intervention.6  
Although support groups, in general, are widely available for a variety of hereditary diseases, 
groups tailored to individuals with a hereditary predisposition to pancreatitis are rare. 
Major aims of support groups are to improve physical function, coping skills, and quality 
of life in patients suffering from chronic pain.  Group approaches offered to chronic pain patients 
are common and give several benefits, such as mutual support, feedback, and active 
participation.29, 31  In summary, there may be a need for support services that are specific to this 
population of individuals. 
More research efforts are needed to clarify further whether individuals with chronic pain 
report a quality of life that necessitates intervention services.  This study was designed to 
document the level of patient reported pain and patient reported quality of life from individuals 
with pancreatitis.  The association of these two factors will allow researchers to explore whether 
intervention in this population is warranted, as well as eventually  to develop a protocol for 
targeting  patients who would benefit based on these variables.  It was expected that Hereditary 
Pancreatitis patients would report a severe level of chronic pain and a poor overall quality of life 
to support the need for a psychosocial and behavioral intervention in the form of a support group. 
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1.1 SPECIFIC AIMS 
Specific Aim 1: To document the levels of patient reported pain and patient 
reported quality of life (using the Short Form-12® Quality of Life 
survey) for individuals with pancreatitis. 
Hypothesis: Patients with Hereditary Pancreatitis will report high levels of 
chronic pain and poor quality of life in both physical and mental 
subsets. 
Plan: HP study and NAPS2 study participants filled out a questionnaire;  
patients are required to assess their pattern of pain based on level 
of severity and frequency.  Questions assessing physical and 
mental well-being are also included. Patient-reported pain will be 
compared between those who reported hereditary pancreatitis 
versus non-hereditary pancreatitis.  Pain level and patient genotype 
will also be compared. 
Specific Aim 2: To explore whether the need for intervention services such as the 
implementation of a support group for patients with Pancreatitis 
exists. 
Hypothesis: Patients with chronic pain attributed to HP would benefit from 
psychosocial and behavioral treatment in the context of a support 
system. 
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Plan: The responses to thirteen questions involving pain and the SF-12®  
Version 1 survey will be analyzed to see if measures are severe 
enough to warrant additional support. 
 
1.2 BACKGROUND AND SIGNIFICANCE 
1.2.1 Pancreatitis Studies 
The Hereditary Pancreatitis Study was initiated by David C. Whitcomb, MD, PhD in 1995 at the 
University of Pittsburgh.  The study’s original aim was to evaluate the distribution of HP in the 
United States and to determine the major gene mutation that causes HP.  Families were recruited 
through referrals from collaborating centers, other physicians, and self-referral of patients.  
Family histories were constructed, questionnaires completed and blood samples drawn for each 
proband and participating family members. Over 200 families have been recruited to date. 
Following studies have looked at new approaches to prevention and therapy.7
The North American Pancreatitis Study II is a multi-site collaborative study consisting of 
20 study centers across the United States.  The NAPS2 study was initiated in 2002 in order to 
determine the genetic and environmental factors contributing to pancreatitis.  Participants were 
recruited from collaborating centers.  The study has enrolled over 1,000 patients with acute or 
chronic pancreatitis.8
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1.2.2 Features of Pancreatitis 
Acute pancreatitis is a potentially life-threatening condition presenting with severe abdominal 
pain. Acute pancreatitis is initiated with injury to the pancreas, followed by an acute 
inflammatory response and associated complications.  When a person has acute pancreatitis the 
amounts of amylase and lipase in the blood are often elevated.  With pancreatic rest, IV fluids, 
and pain medications recovery occurs within approximately a week.  After acute pancreatitis the 
pancreas typically returns to normal, but scarring may occur. Patients with recurrent acute 
pancreatitis are at risk of developing chronic pancreatitis.  Individuals with chronic pancreatitis 
are at increased risk of developing pancreatic cancer.   The risk of pancreatic cancer in hereditary 
cases of pancreatitis is greater than 50 times the general population risk.17  
Chronic pancreatitis occurs following persistent attacks of acute pancreatitis. Chronic 
pancreatitis is characterized by irreversible scarring of the pancreas with a permanent loss of 
pancreatic function and is often associated with unrelenting abdominal pain.16 The permanent 
structural changes in the pancreas lead to impairment of exocrine and endocrine function.  When 
the pancreas has a considerable amount of scarring, individuals are unable to digest food 
properly (exocrine insufficiency) due to acinar cell loss  and have trouble controlling their blood 
sugar (diabetes mellitus) due to islet cell loss. 16 
 
1.2.3 Features of Hereditary Pancreatitis 
Hereditary pancreatitis (HP) is a rare and unusual form of acute and chronic pancreatitis.  HP 
accounts for only 2-3% of all cases of chronic pancreatitis. It is estimated that at least 1,000 
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individuals in the United States are affected with hereditary pancreatitis.  Onset of attacks can 
begin at any age, but typically begin within the first two decades of life, with pain being one of 
the most distressing symptoms.  Various options are available for treatment of pain, but they 
provide limited relief for short periods of time.   
1.2.3.1 Risk Factors and Causes of Pancreatitis 
The pathogenesis of pancreatitis appears to be multifactorial, meaning that the risk to develop 
pancreatitis is heavily influenced and dependent on the interaction of hereditary and 
environmental exposures.   
Acute pancreatitis can occur secondary to several different factors.  A long history of 
alcohol use (usually 10 to 20 years) is the most frequently observed cause of acute pancreatitis.  
Individuals who have undergone surgery or who have had trauma to the abdominal area may 
develop acute pancreatitis.  Also, acute pancreatitis can be drug-induced.  Some individuals who 
are on certain medications are at higher-risk for developing pancreatitis, including: patients with 
AIDS on DDI, with Crohn’s disease on 6-mercaptopurine, or on ACE inhibitors with a history of 
angioedema.  In addition, individuals who have prior episodes of biliary colic and/or cholangitis 
are at increased risk for developing gallstones and in turn pancreatitis.  Finally, individuals with 
familial hypertriglyceridemia or sporadic hypertriglyceridemia are at an increased risk of 
developing acute pancreatitis.9  In about 15% of cases, the cause of acute pancreatitis is 
unknown. 
The TIGAR-O risk factor classification system lists several major factors associated with 
chronic pancreatitis.10 These risk factors are categorized into six groups. 
• Toxic-Metabolic 
o Alcohol abuse11 (Alcohol abuse is the cause of 70-80% of pancreatitis cases.) 
 6 
o Chronic smoking12 
o Hypercalcemia 
o Hyperlipidemia 
o Chronic renal failure 
o Medications 
o Toxins 
• Idiopathic 
o Early/late onset 
o Tropical 
• Obstructive 
o Panreatic Divisum 
o Sphincter of Oddi disorders 
o Duct Obstruction 
o Preampullary duodenal wall cysts 
o Posttraumatic pancreatic duct scars 
• Systemic disease (lupus erythematosus, cystic fibrosis, and hyperparathyroidism) 
• Autoimmune  
o Sjogren’s syndrome 
o Primary biliary cirrhosis  
o Isolated autoimmune chronic pancreatitis13 
• Recurrent and severe acute pancreatitis 
o Postnecrotic 
o Recurrent acute pancreatitis 
o Vascular diseases/ischemic 
o Postirradiation 
• Genetic 
o Autosomal Dominant (PRSS1) 
o Autosomal Recessive (SPINK1/CFTR) 
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All of these risk factors for the development of chronic pancreatitis are therefore risk 
factors for pancreatic cancer.  Approximately 32,180 patients are diagnosed with pancreatic 
adenocarcinoma each year; it is the fourth leading cause of cancer deaths among Americans.14 
Generally, pancreatic cancer is rare before the age of 45, but hereditary factors can predispose an 
individual to pancreatic cancer with a 40% lifetime risk to developing pancreatic cancer. 
Pancreatic cancer also aggregates in some families without hereditary pancreatitis, but with some 
other underlying hereditary cause. 
1.2.3.2 Clinical Presentation and Diagnosis15, ,16 17 
Pancreatitis causes structural changes in the pancreas, which lead to a disruption of endocrine 
and exocrine function.  The three primary clinical manifestations of chronic pancreatitis are 
abdominal pain, diabetes and pancreatic insufficiency, though other health problems result as 
well. 
Abdominal pain is the hallmark feature of chronic pancreatitis.  The pain is usually 
epigastric and radiates to the back.  Abdominal pain due to pancreatitis has been described by 
patients as stabbing, boring, burning, sharp, and gnawing.  Fever, nausea, vomiting, and marked 
elevation of serum amylase often accompany the abdominal pain.  The pain is typically the worst 
in the 15-30 minutes directly following eating.  It may occur in attacks, but as pancreatitis 
progresses, individuals usually experience continuous pain.18
The type and pattern of pain varies from patient to patient.  Most individuals fall within 
two patterns of pain.  Some experience episodes of pain that last several days.  Between these 
episodes are periods without pain that span several months to a few years.  The second pattern of 
pain is characterized by prolonged periods of pain occurring on a daily basis with episodes of 
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severe pain.  Not all patients affected by pancreatitis experience pain, although it is the most 
common clinical complaint. 
Pancreatic insufficiency is the second major clinical feature of pancreatitis.  Proper 
digestion of complex foods is dependent on adequate pancreatic exocrine function.  Individuals 
with pancreatitis may have severe exocrine dysfunction.  Clinically significant symptoms of 
exocrine dysfunction do not typically occur until the majority, approximately 90%, of pancreatic 
function is lost.19  As a result of exocrine insufficiency, fat malabsorption causes loose, greasy, 
foul smelling stools that are difficult to flush. 
Intolerance to glucose progressing to diabetes mellitus occurs frequently in pancreatitis. 
Most patients eventually require treatment with insulin.  The difference between diabetes 
mellitus associated with HP and type 1 diabetes is an increased risk of hypoglycemia due to the 
affected pancreatic alpha cells that still produce glucagon. 
Other health complications of pancreatitis include bile duct or duodenal obstruction, 
pseudocyst formation, pancreatic ascites or pleural effusion, pseudoaneurysms, and splenic vein 
thrombosis. 
Differentiation between hereditary pancreatitis and familial paroxysmal peritonitis 
(familial mediterranean fever characterized by paroxysmal attacks of fever and inflammation.) is 
difficult except for the occurrence of an elevation in serum amylase associated with 
pancreatitis.18  However, Mediterranean fever is rare in the United States. 
1.2.3.3 Genetics of Hereditary Pancreatitis20, , , 21 22 23 
Hereditary pancreatitis is an autosomal dominant genetic disorder; the symptoms of HP are 
caused by a change in a specific gene that is passed through a family.  Sixty to seventy percent of 
hereditary pancreatitis families have been found to have a mutation in a single gene.  The 
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cationic trypsinogen gene (PRSS1) has been localized to chromosome 7q35 and produces the 
cationic trypsinogen enzyme, which breaks down the protein in food.  Currently, two common 
mutations and six more uncommon mutations that are associated with hereditary pancreatitis 
have been identified.  The known common mutations are R117H and N291. It is thought that 
some individuals with hereditary pancreatitis do not have a mutation in this gene; thus, there are 
most likely additional genes and mutations that cause HP.  There is a great deal of variety in the 
frequency and severity of pancreatic attacks for people who inherit a mutation in the PRSS1 
gene, with some individuals never developing symptoms.   Individuals who have inherited either 
of the common mutations have an 80% risk of developing clinical symptoms of HP by age 20 
years.  Mutations in the serine protease inhibitor, Kazal type, 1 (SPINK1), a pancreatic trypsin 
inhibitor, have also been identified in HP patients.24  
Trypsin plays an important role in digestion.  The enzyme trypsinogen is made in the 
pancreas in an inactive form.  Trypsinogen is activated to trypsin in the intestine and in turn 
activates all other digestive enzymes (Figure 23- Appendix B).   If trypsinogen is activated in the 
pancreas (trypsin), activation of other digestive enzymes can cause the pancreas to begin 
digesting itself.  Normally, active trypsin destroys itself by cutting at R122 (arginine 122); thus, 
splitting trypsin and inactivating it.  In hereditary pancreatitis, R122 is mutated to H122 
(histidine 122) blocking the splice site and, therefore trypsin cannot be inactivated.  This leads to 
acute pancreatitis.  The other known trypsin mutation, N291 is a substitution in the trypsin  
molecule.  This mutation facilitates pancreatitis by causing early activation. 
SPINK1 is a protective measure that acts as a trypsin inhibitor that neutralizes about 20% 
of pancreatic trypsin activity. SPINK1  codes for pancreatic secretory trypsin inhibitor (PSTI), 
which is a serine protease inhibitor that inhibits premature activation of trypsin in the pancreas. 
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Mutations in these inhibitory mechanisms are associated with juvenile chronic hereditary 
pancreatitis, and are also associated with a complex autosomal recessive pattern of inheritance. 
Prior to the discovery of genes associated with hereditary pancreatitis, the cystic fibrosis 
transmembrane conductance regulator (CFTR) gene was identified as being associated with 
acute and chronic idiopathic pancreatitis.  Many groups have identified and confirmed this 
association between mutations in the CFTR gene and recurrent pancreatitis.25  THE CFTR 
mutations prevent water from entering the pancreas due to osmosis.  Thus, the enzymes are not 
flushed from the pancreas to the intestine.  Trypsinogen is then activated while still in the 
pancreas causing digestion. 
Proteinase Activated Receptors (PAR) are cell surface receptors that are known to play a 
critical role in pancreas inflammation.  The proteinase-activated receptors are a family of four G-
protein-coupled receptors that are activated by trypsin.  PAR is expressed in the pancreas and 
small intestine and plays a role in inflammation.  PAR has been shown to be involved with the 
activation of nociceptive neurons in the thoracic dorsal root ganglia.  Mutations in the PAR gene 
induce a pain response in the pancreas.  Therefore, PAR plays in important part of the 
pathogenesis of pancreatic pain.26, 27
1.2.3.4 Genetic Testing 
Genetic testing for hereditary pancreatitis is very important because it is clinically 
indistinguishable from other causes of pancreatitis.  Genetic testing, in additiona to other tests, 
can also help differentiate possible diagnoses of abdominal pain including: cystic fibrosis, 
hyperlipidemia, familial hyperchylomicronemia, homocystinuria, hyperparathyroidism, and 
familial hypocalciuric hypercalcemia.  Site specific genetic testing for mutations in the cationic 
trypsinogen gene (PRSS1) is based on polymerase chain reaction (PCR) amplification of two 
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exons followed by restriction-enzyme digestion of the products.  In the majority of cases, 
hereditary pancreatitis can be attributed to severe mutations such as R122H and N291.  Not all 
individuals with early onset severe disease have a corresponding genotype.   
Genetic testing is available through Ambry Genetics.  To account for all genetic 
variations in the major pancreatic enzyme PRSS1 gene, analysis of the entire coding region is 
performed.  In addition to analysis of the PRSS1 gene, Ambry provides complete sequencing of 
CFTR and SPINK1 because they have been identified as risk factors in chronic pancreatitis.  The 
comprehensive genetic test for pancreatitis is capable of detecting greater than 98% of all 
(greater than 1,300) known mutations in the CFTR gene, as well as providing complete 
sequencing of PRSS1 and SPINK1.28
Genetic testing is indicated when individuals have recurrent attacks of acute pancreatitis 
with no explanation, unexplained chronic pancreatitis, a family history of pancreatitis, and/or an 
unexplained episode of pancreatitis in childhood. Genetic testing guidelines for hereditary 
pancreatitis are published by The National Guideline Clearinghouse.29
1.2.3.5 Management and Treatment of Hereditary Pancreatitis30, ,31 32 
Most therapies and treatments for pancreatitis are aimed at relief of pain, correction of pancreatic 
endocrine and exocrine insufficiency, and management of resulting complications. Control of 
abdominal pain can prove difficult due to the wide spectrum of presentation.  The heterogeneity 
of the population, subjective nature of pain, and poor understanding of pathophysiology are all 
obstacles in studying the effectiveness of pain management.  In general, pain management 
should proceed in a stepwise approach including: establishing a secure diagnosis, pancreatic 
enzyme supplementation, and analgesics administration.  Pancreatic enzymes such as Creon, 
Pancrease, and Violiase are helpful in improving digestion and reducing diarrhea and pain for 
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patients with more advanced disease.33  Dietary treatment is also used to help control pain with 
digestion including the consumption of small meals that are high in carbohydrates and low in 
protein and fat.  Patients with persistent symptoms can be treated with more invasive options in 
specialized centers.  Furthermore, many centers use interdisciplinary approaches to cover all 
aspects of pain management.  Some available modalities include: medical management, 
acupuncture, radiographically guided injections, relaxation training and imagery, intravenous 
infusions, neuromodulation, and implantable technologies. Although there is no established 
standard of care, the American Gastroenterological Association (AGA) has set forth management 
guidelines in the form of an algorithm (Figure 24-Appendix B) on the treatment of pain in 
chronic pancreatitis. 
1.2.4 Chronic Pain 
Managing patients with chronic pain is a challenge to health professionals.  Roughly 7-11% of 
the general population is affected by chronic pain.  Generally, multiple interventions are required 
to reduce pain level.34   Previous studies on chronic pain have showed that pain has a profound 
effect on the lives of those with chronic conditions.  Many people with chronic pain believe that 
it affects their emotional well being.  People in pain generally experience feelings of depression, 
anxiety, anger, helplessness and/or hopelessness.  These effects of pain can interact with and 
exacerbate an already difficult situation by increasing pain.21  Patients report that they feel they 
are not believed about their chronic pain condition and its impact on their lives.  Individuals with 
chronic pain are often unaware of what support services and treatments exist.  Participants found 
it helpful to attend group sessions with health care professionals to learn how to cope with 
chronic pain.  Coping is defined as the intentional and effortful attempt to adapt pain.35  Part of 
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the coping process is the recognition that a cure for chronic pain is very unlikely and the need to 
focus on non-pain aspects of life rather than pain aspects.36  The level and severity of pain may 
control the effectiveness of coping strategies.   
Patients with mild to moderate pain rather than high-intensity pain have greater feelings 
of control that allow for better social functioning. The acceptance of pain has a contribution to 
mental well-being beyond the effect of pain severity. Ilse et. al.  found that high levels of mental  
and physical health were related to lower levels of pain severity when evaluated by the SF-36® 
health survey.  The study also showed that greater acceptance of pain was associated with better 
mental health. 
Herrmann et. al. conducted a study investigating the coping skills of HP patients.  The 
study concluded that patients with HP are more likely to use passive coping strategies than active 
coping strategies.  Passive coping strategies do not require effort (such as worrying).  Active 
coping strategies do require effort and focus, such as engaging in activities.  People who use 
active coping strategies feel more control over situations where they have no control, for 
example pain.  This approach to coping with pain improves overall daily functioning.  Increased 
emotional tension, as a result of the level of pain combined with the management of everyday 
stressors (for example: school, work, children), interferes with the ability to use active coping 
methods.  The stressors are too physically, mentally, and emotionally taxing, which hinder 
attempts at active coping strategies.  Overall, Herrmann found that an outlet such as a support 
group or therapy would allow these patients to learn how to cope with a chronic illness.37
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1.2.5 The Short-Form 12® Health Survey (Version 1) 
The SF-36® survey is a brief, comprehensive measure of general health status designed for use in 
clinical practice and research, evaluation of health policy, and general population surveys.  The 
SF-12® Health Survey is a subset of the SF-36® designed at The Health Institute in 1994. The 
survey was designed to measure general health status, including physical, social, and emotional 
functioning from the patient’s point of view. This subset provides only physical and mental 
health subscores, not individual domain scores.38  The reliability and validity of the subset 
version is slightly lower than that of the SF-36®, but when used with large sample size and an 
objective to monitor overall physical and mental health outcomes, the SF-12® Health Survey is a 
satisfactory alternative. The survey includes eight concepts commonly represented in health 
surveys: physical functioning, role functioning physical, bodily pain, general health, vitality, 
social functioning, role functioning emotional, and mental health.39  Each dimension of the 
survey is scored on a scale from 0 to 100, with higher scores indicating better health.40  The SF-
12® can apply in any context of age or disease and is therefore a useful tool for surveying the 
general population. The general health survey has been used to analyze quality of life in many 
contexts.  In cases of chronic conditions and postoperative patients this tool has been able to 
show marked improvement in the patient’s quality of life.41
1.2.6 Support Groups 
1.2.6.1 History of Self-Help and Support Groups in the United States 
Support groups are often comprised of individuals who share experiences or who face the same 
issues.  A support group is a group that meets for the purpose of exchanging information or 
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advice, and providing emotional support.  Support groups focus on the support and education of 
the group as a whole.  The group is typically led by a health professional and is likely to be 
linked to a larger, formal organization, although groups can be led and organized by its 
members.42  Aspects of the group’s focus include personal growth or change.  Such groups 
provide many benefits: a chance to learn from others’ experience, suggestions about coping, 
support and encouragement, friendship, and reduction of guilt.  
Dating back to the 1800’s, immigrants arriving to the United States sought out others that 
shared common backgrounds for support.43  These groups joined to address many issues such as 
language and religion problems and feelings of intolerance and isolation.  
The majority of documented support groups deal with substance-related addiction.  Over 
time, substance control self-help groups have been established to cater to different subgroups of 
people, and different problem areas.  With the establishment of Alcoholics Anonymous in 1935, 
self-help groups gained increasing popularity.  Health care professionals began to play an 
important role in the formation of self-help or support groups.  Many health care fields attempted 
to use these groups to offer non-directive services to patients.  Using this theory, these services 
began to allow patients to their own advocates in health management.  These changes led to the 
increased and ever growing availability of support groups for patients. 
Many research studies have been conducted analyzing the effectiveness of chronic illness 
support groups; most studies have shown that members benefit from participation.44 Group 
participants reported decreased psychological problems, a more positive outlook on life, greater 
satisfaction with their medical care, increased self-esteem, and decreased feelings of shame.  One 
study conducted on a chronic illness support group for pain reported that members experienced 
significantly less disability and that the support group helped them in their daily lives.  In 
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addition to benefits previously cited, members reported learning about coping strategies, learning 
increased motivation, and learning to adapt to life with pain.23
1.2.6.2 Genetic Support Groups 
Following the evolution of support groups, a large number of organizations were formed to deal 
with the issues accompanying genetic diseases.  The occurrence of genetic disease may have a 
strong impact on an individual because they usually affect a person throughout his/her life, have 
implications for more than one family member, involve complex scientific concepts, and have no 
cure.  The effects of a genetic disease on an entire family system may include powerful feelings 
of guilt, shame, fear, and blame.  Often, individuals with a genetic disease experience feelings of 
social isolation.  The development of genetic support groups helps to reduce some of these 
feelings among individuals and families, as well as aiding in teaching and providing information 
surrounding medical management.  In this way, genetic support groups play a vital role in the 
health care of affected individuals and their families.  Directors and healthcare professionals in 
these groups provide a wide range of support services to individuals with genetic diseases.  
Today many networks of support services exist, including The National Organization for Rare 
Disorders (NORD).  The NORD’s Organizational Database provides information on more than 
2,000 disease-specific support groups, registries, agencies, and organizations that serve the needs 
of rare diseases.45
Current literature reports few supportive medical services for individuals with Hereditary 
Pancreatitis.  The extensive database of the NORD does not include a support group for 
individuals with Hereditary Pancreatitis.  One self-help organization for pancreatitis was 
identified in the United Kingdom: Pancreatitis Supporters Network.  Recently the National 
Pancreas Foundation has created on on-line email list for patients with pancreatitis. 
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2.0  EXPERIMENTAL DESIGN AND METHODS 
2.1 QUESTIONNAIRES 
The questionnaires used for this study were created by investigators of the North American 
Pancreatitis Study II (NAPS2) and the Hereditary Pancreatitis (HP) study at the University of 
Pittsburgh (Division of Gastroenterology, Hepatology, and Nutrition), and approved for research 
purposes by the Institutional Review Board of the University of Pittsburgh in Pittsburgh, 
Pennsylvania.  Informed consent for participation in the studies was obtained from participants 
prior to filling out the questionnaires.  The NAPS2 survey  (Appendix C) included 76 multiple-
choice and short answer questions for the subjects.  The HP survey (Appendix E) also included 
76 multiple-choice and short answer questions.  Multiple opportunities exist throughout both 
questionnaires for respondents to elaborate on their answers and provide personal comments.  
The NAPS2 study questionnaire was distributed to participants through twenty study centers 
throughout North America. Study centers were recruited from the Mid-Atlantic Pancreatitis 
Study. 
Questions and data used for this study were extracted from the two questionnaires.  In 
total, 13 multiple-choice questions were used for this study.  Of these, twelve questions are from 
the SF-12® Health Survey (Version 1), and the last is a two-part question regarding pain.  The 
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data from 73 subjects from the two studies who reported a family history of pancreatitis were 
used in this study. 
For the first question, the respondents were asked to categorize their pattern of pain.  In 
addition to the pattern of pain, questions regarding respondent’s views about their general health, 
with respect to how they feel and how well they are able to do usual daily activities, were 
presented (SF-12®).   All responses and family history information were entered into a 
computerized database, Progeny Version 5.0.  Pertinent questions were then queried and 
extracted from the database. 
2.2 DATA ANALYSIS 
The SF-12® physical and mental health scales are scored using norm-based methods.  The 
scoring involves four steps.  The first step is to convert each item response choice category into 
an indicator variable (0-5).  The indicator variables are weighted (using physical and mental 
regression weights from the 1990 general U.S. population) and aggregated.  The 1998 constant 
(regression intercept) is then added so that the aggregate scores are standardized to have the 
same mean as SF-36® versions in the general U.S. population.  
Results of the SF-12® were expressed in terms of two meta-scores: the Physical 
Component Summary (PCS) and the Mental Component Summary (MCS).  To calculate the PCS 
and MCS scores, test items were scored and normalized in a complex algorithm.  Scores ranging 
from 0 to 100 were designed to have a mean score of 50 and a standard deviation of 10 in a 
representative sample of the 1990 US population (Table 22- Appendix A). 
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Relationships between reported pain or quality of life and environmental factors (study, 
family history, age, gender, smoking, alcohol, and diabetes) were analyzed by box and whisker 
plots. Comparisons between the familial and non-familial groups were carried out using Mann-
Whitney U test or, if the outcomes were normally distributed, 2-sample t-tests.  Combined rank 
scores were subdivided by severity and duration based on preliminary trends seen with the 
combined pain scores.  Ranks for severity and duration were combined into two levels.  The 
severity group was separated into a mild to moderate pain group and a severe pain group.  For 
duration, responses were divided by episodes and constant pain.  To incorporate all aspects of 
pain (frequency, duration, character, and severity) a pain measure variable was calculated.  Each 
variable is weighted with the average.  The comprehensive pain measure was calculated using 
the formula: 
 
Pain Measure = ((# episodes per month – average # episodes per month)/standard deviation 
of episodes per month)) + (Combined Pain Score-2.5) + (Pain Severity – 0.5) + (Pain 
Duration – 0.5)  
Data analysis also consisted of pairwise correlations between SF-12® scores and 
combined rank pain scores.  Regression analysis was also performed with the covariates for the 
total population, familial subpopulation, and non-familial subpopulation.  Statistical analyses 
were performed using the statistical software package Stata Version 7.0.   
 20 
3.0  RESULTS 
3.1 DEMOGRAPHICS 
Data from 73 patients that reported having hereditary pancreatitis were used in this study.  Of 
these, 28 patients were from the HP study and 45 from the NAPS2 study.  Data from 271 non-
familial patients from the NAPS2 study were also used.  Table 1 illustrates the characteristics of 
the participants by several categories including: gender, age, age at first diagnosis, smoking, 
alcoholism, and type of pancreatitis. In both the familial and non-familial groups a higher 
proportion of patients were female than male.   Two hundred and eleven (61.34%) subjects 
reported being diagnosed with both acute and chronic pancreatitis.  The proportion of individuals 
who reported a history of smoking and alcohol abuse was higher in the NAPS2 study than the 
HP study, but non-familial subjects were more likely to use tobacco than alcohol.  The age of 
study participants ranged from 9 to 79, with a mean age of 44.8 years.  The age at first diagnosis 
of study participants ranged from 2 to 74, with a mean age at first diagnosis of 29.9 years.  The 
age of non-familial subjects ranged from 8 to 91, with a mean age of 48.48 years.  The age at 
first diagnosis of non-familial subjects ranged from 4 to 77, with a mean age at first diagnosis of 
41.11 years.  
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Table 1. Demographic Information 
 HP Study NAPS2 Study Non-familial Total 
Gender 
Male 
Female 
 
12 (42.86%) 
16 (57.14%) 
 
17 (37.78%) 
28 (62.22%) 
 
145 (53.51%) 
126 (46.49% 
 
174 (50.58%)
170 (49.42%)
Age 
<20 
20-29 
30-39 
40-49 
50-59 
60-69 
70-79 
≥ 80 
 
7 (25.00%) 
3 (10.71%) 
2 (7.14%) 
5 (17.86%) 
5 (17.86%) 
3 (10.71%) 
3 (10.71%) 
0 (0%) 
 
1 (2.22%) 
2 (4.44%) 
13 (28.89%) 
9 (20.00%) 
10 (22.22%) 
7 (15.56%) 
3 (6.67%) 
0 (0%) 
 
6 (2.21%) 
25 (3.23%) 
40 (14.76%) 
68 (25.09) 
69 (25.46%) 
43 (15.87%) 
15 (5.54%) 
4 (1.48%)** 
 
14 (4.07) 
14 (4.07%) 
55 (15.99%) 
82 (23.84%) 
84 (24.42%) 
53 (15.41%) 
21 (6.10%) 
4 (1.16%) 
Age at First 
Diagnosis 
<20 
20-29 
30-39 
40-49 
50-59 
60-69 
70-79 
≥ 80 
 
 
16 (57.14%) 
5 (17.86%) 
1 (3.57%) 
3 (10.71%) 
2 (7.14%) 
0 (0%) 
0 (0%) 
0 (0%)* 
 
 
6 (13.33%) 
8 (17.78%) 
9 (20.00%) 
10 (22.22%) 
7 (15.56%) 
3 (6.67%) 
2 (4.44%) 
0 (0%) 
 
 
20(7.38%) 
52 (19.19%) 
51 (18.82%) 
65 (23.99%) 
46 (16.97%) 
22 (8.12%) 
12 (4.43%) 
1 (0.37%)*** 
 
 
22 (30.14%) 
13 (17.81%) 
10 (13.70%) 
13 (17.81%) 
9 (12.33%) 
3 (4.11%) 
2 (2.74%) 
0 (0%) 
Smoking 
No 
Yes 
 
19 (67.86%) 
9 (32.14%) 
 
15 (20.54%) 
30 (41.10%) 
 
111 (40.96%) 
154 (56.83%)*4
 
145 (42.15%)
193 (56.10%)
Alcoholism 
No 
Yes 
 
20 (71.43%) 
8 (28.57%) 
 
28 (62.22%) 
17 (37.77%) 
 
166 (61.25%) 
103 (38.01%)*5
 
214 (62.21%)
128 (37.21%)
Type of 
Pancreatitis 
Chronic 
Acute 
C & A 
 
 
4 (14.29%) 
11 (39.3%) 
13 (46.43%) 
 
 
9 (20.0%) 
12 (26.7%) 
24 (53.3%) 
 
 
54 (19.93%) 
43 (15.87%) 
174 (46.43%) 
 
 
67 (19.48%) 
66 (19.19%) 
211 (61.34%)
*One patient did not report age at diagnosis. 
** A date of birth was not available for one patient. 
*** Two patients did not report age at diagnosis. 
*4 Six patients did not report tobacco use. 
*5 Two patients did not report alcohol consumption. 
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3.2 ASSIGNED VARIABLES FOR ANALYSIS 
For all statistical analysis (performed using Stata Version 7.0), text variables were converted into 
the numerical responses listed in Table 2.   
 
Table 2. Assigned Variables 
COVARIATES ASSIGNED VARIABLES 
Study HP = 0 NAPS2 = 1 
Hereditary Familial = 0 Non-familial = 1 
Genotype Normal Allele = 0 Mutated Allele = 1 
Gender Male = 0 Female = 1 
Smoking No = 0 Yes = 1 
Alcoholism No = 0 Yes = 1 
Diabetes No = 0 Yes = 1 
Pain Severity Mild to moderate = 0 Severe = 1 
Pain Duration Episodes = 0 Constant = 1 
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3.3 SPECIFIC AIM 1 
3.3.1 Combined Pain Index 
Study participants were asked to rank their level of pain on a scale from “mild to moderate 
episodes of pain” to “severe constant pain.”  In order to describe the patients’ reported pain level 
across both studies a combined ranking score based on severity and duration of pain was 
designed.  Table 3 displays the combined scores.  The description of pain are the responses 
available to participants in the questionnaire.  The pain index simply gives each response a 
numerical counterpart.   
 
Table 3. Combined Pain Rank Scores 
COMBINED 
PAIN 
INDEX 
DESCRIPTION OF PAIN 
(by Severity and Duration) FAMILIAL 
NON-
FAMILIAL 
0 No pain 5 (6.85%) 0 (0%) 
1 Mild-moderate episodes of pain 6 (8.22%) 35 (12.92%) 
2 Constant mild-moderate pain 2 (2.74%) 22 (8.12%) 
3 Severe episodes of pain 18 (24.66%) 106 (39.11%) 
4 Constant mild pain, and episodes of severe pain 27 (36.99%) 89 (32.84%) 
5 Constant severe pain 7 (9.59%)* 19 (7.01%) 
* Eight (10.96%) subjects did not report their level of pain. 
 
Therefore, a combined rank of 1 is the mildest form of pain with the shortest duration 
period, and a combined rank of 5 is the most severe level of pain with the longest duration.  
Combined pain index scores were also analyzed by comparison to several environmental 
factors and exposures for both pancreatitis groups collectively.  The total pain ranks were 
compared to patient responses of tobacco use, alcohol use, gender, and diagnosis of diabetes.  
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Each environmental exposure was also evaluated within each group, familial and non-familial. 
No significant trends were found in this analysis. 
In addition to scoring their level of pain, subjects who reported a severe level of pain 
were required to quantify the frequency of severe episodes per month and per year.  Because 
many different measures of pain were extrapolated from the questionnaires, an overall pain 
measure was calculated to capture all pain descriptions.  Four pain measures- frequency, 
character, severity, and duration- were weighted and combined for each individual.  The 
distribution of the pain measure for the total population is shown in Figure 1, and is 
approximately normal. 
Total Pain Measure
PainMeasure-4.040018 8.686656
 
Figure 1. Total Pain Measure 
 
In addition to examining pain responses by study and environmental exposures, pain was 
compared with genotype.  Genotypes for forty-five patients existed, representing the PAR, 
SPINK1, and PRSS1 genes.  Several patients were found to have mutations in more than one 
tested gene, and six subjects tested negative for all three genes.  These proportions of patients  
have atleast one mutation in the indicated gene (except for the negatives).  This distribution is 
shown in Figure 2. 
 25 
 Genotype Distribution
PAR
36%
SPINK1
29%
PRSS1
22%
Negative
13%
PAR
SPINK1
PRSS1
Negative
 
Figure 2. Genotype Distribution 
 
Genotype variables were assigned as shown in Table 2, and were grouped by mutated and 
normal alleles.  The mutant alleles were scored as 1, and the normal as 0.  For individuals who 
were found to have a PAR mutation, as shown above, 75% were carriers, and 25% homozygous 
for the risk allele.  Genotypes were compared against the combined pain scores, pain severity, 
and pain duration.  Figure 3 shows the combined pain rank scores for each of the three genes. 
 
Total Combined Pain Rank Stratified by Genotype
0
5
 Pain
0 1 2
 
Figure 3. Total Combined Pain Rank Stratified by Genotype 
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 No significant difference appear to be seen between the genotypes in terms of the 
combined pain scale.   
3.3.2 SF-12® v1 Analysis 
The SF-12® analysis consisted of a complex algorithm based on population data from 1990.  The 
outcomes for each measure were added to a 1996 constant (based on general population 
responses) to obtain the final Physical and Mental Weight scores.  Higher scores equate to a 
better quality of life.  Scores for the familial and non-familial physical component ranged from 
4.34 to 59.45 and 10.05 to 72.26, respectively.  The familial mental score range was -11.10 to 
58.87 and the non-familial mental score range was -10.38 to -52.10.  The values for the total 
physical quality of life are shown in Figure 4. 
Total Physical Quality of Life Measure
PWS-10.13364 59.44613
 
Figure 4. Total Physical Quality of Life 
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Figure 5 below shows the distribution of the mental quality of life outcomes, which also 
appear to be normally distributed for the total population. 
 
Total Mental Quality of Life Measure
MWS-11.1037 58.87008
 
Figure 5. Total Mental Quality of Life 
 
Figures 6 and 7 show the physical and mental quality of life measures for the familial 
population and non-familial population, respectively. 
 
P
W
S
Familial QOL
MWS
-11.1037 58.8701
4.34483
59.4461
 
Figure 6. Familial QOL Outcomes 
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Non-familial QOL
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Figure 7. Non-Familial QOL Outcomes 
 
Figure 8 shows the physical and mental quality of life measures for the familial versus 
non-familial subpopulations. 
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Figure 8. TotalQuality of Life Outcomes 
 
Although outcomes varied greatly, a subtle trend can be seen between physical and mental 
weight scores as quality of life increases. Familial (0) physical and mental health compared with 
non-familial (1) physical and mental health showed a significant difference (p = 0.000 and p = 
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0.000 respectively). 
 
Familial VS. Nonfamilial PWS and MWS
-11.1037
72.2559
 MWS  PWS
0 1
 
Figure 9. Familial versus Non-Familial Quality of Life 
 
In both subgroups physical health was reported to be better than mental health. (In Figure 9, 
MWS is the left box-and-whisker plot for each subgroup)     
Quality of life was also assessed by comparison with other patient specific environmental 
factors including gender, diabetes, alcohol consumption and tobacco use.  These exposures were 
compared within the whole population and by subpopulation (familial, non-familial) 
independently to assess whether they had a significant impact on quality of life.  Outcomes are 
available in Tables 7-8 and 12-13.  
3.3.3 Impact of Pain on Quality of Life 
In order to determine the impact of chronic pain associated with pancreatitis on quality of life a 
variety of analyses were performed.  Each quality of life outcome was assessed based on type of 
 30 
pain categorized by the combined rank.  A trend in responses is apparent; those with pain 
categories including moderate to severe pain reported a lower physical quality of life (Figure 10). 
 
 
4.34483
72.2559
 PWS
0 1 2 3 4 5  
Figure 10. Total Physical QOL Versus Combined Pain Rank 
 
The distribution of quality of life measure combined with the pain characterization is 
displayed in Figure 11. 
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S
Total Physical QOL Stratified by Type of Pain
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-10.1336
59.4461
 
Figure 11. Total Physical Quality of Life Stratified by Type of Pain 
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 Figure 12 shows the mental health scores for each pain category.   
 
-11.1037
62.1066
 MWS
0 1 2 3 4 5  
Figure 12. Total Mental QOL Versus Combined Pain Rank  
 
Individuals with no pain reported the best mental health, although there was not a significant 
difference between the other measures of pain.  Individuals with constant pain, regardless of 
severity reported lower mental quality of life.  Figure 13 shows the distribution the pain character 
with mental quality of life outcomes. 
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Figure 13. Total Mental Quality of Life Stratified by Type of Pain 
 
3.3.4 Impact of Pain Duration and Severity on Quality of Life 
As a result of the trends obtained from pain outcomes, the pain categories were further 
subdivided by duration and severity.  
 
Table 4. Pain Scores Based on Severity and Duration 
GROUPED RANK PAIN SEVERITY PAIN DURATION 
0 0,1,2,3 0,1,3 
1 4,5 2,4,5 
 
Combined pain ranks included in the mild to moderate pain severity grouping were 0, 1, 2, and 3; 
the severe pain grouping consisted of 4 and 5.  Combined pain ranks of 0, 1, and 3 were joined to 
make the episodic pain group; 2, 4, and 5 compose the constant pain group (Table 4).   
Figure 14 shows the groups based on severity of pain (mild to moderate and severe).  Those with  
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severe pain report a statistically significant (p = 0.0007) lower physical quality of life within the 
familial group, and difference in severity was seen in the non-familial group.   
 
Physical QOL by Pain Severity
4.34483
72.2559
 PWS
0 1
 
Figure 14. Total Physical Quality of Life Stratified by Pain Severity 
 
Familial mental QOL was also significantly different between pain severity groups with a 
p-value of 0.0194 (Figure 15). 
 
Familial Mental QOL Stratified by Pain Severity
-11.1037
58.8701
 MWS
0 1
 
Figure 15. Familial Mental QOL Stratified by Pain Severity 
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Figure 16 shows the non-familial mental QOL stratified by pain severity. 
Non-Familial Mental QOL Stratified by Pain Severity
0
3.11028
 MWS
0 1
 
Figure 16. Non-Familial Mental QOL Stratified by Pain Severity 
 
Those study participants with constant pain rather than episodes of pain reported lower levels of 
mental health.  The difference between mental quality of life between pain duration groups for 
the total population did not appear to be significant (Figure 17). 
   
Mental QOL by Pain Duration
-11.1037
62.1066
 MWS
0 1
 
Figure 17. Total Mental QOL Stratified by Pain Duration 
 
When subdivided into familial subjects, the difference between mental (Figure 18) and physical 
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(Figure 19) quality of life between pain duration groups was also evident (p = 0.0141 and p = 
0.0007 respectively). 
 
Familial Mental QOL Stratified by Pain Duration
-11.1037
58.8701
 MWS
0 1
 
Figure 18. Familial Mental QOL Stratified by Pain Duration 
 
Familial Physical QOL Stratified by Pain Duration
4.34483
59.4461
 PWS
0 1
 
Figure 19. Familial Physical QOL Stratified by Pain Duration 
 
When subdivided into non-familial subgroups the difference between mental and physical 
quality of life and pain duration was not significant (Figures 20 and 21). 
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Non-Familial Mental QOL Stratified by Pain Duration
0
3.11028
 MWS
0 1
 
Figure 20. Non-Familial Mental QOL Stratified by Pain Duration 
 
Non-Familial Physical QOL Stratified by Pain Duration
-10.1336
0
 PWS
0 1
 
Figure 21. Non-Familial Physical QOL Stratified by Pain Duration 
 
In addition to assessing pain with quality of life outcomes, comparisons were made with 
common environmental influences.  Counts for each group according to the pain index are 
shown in Table 5.  The physical and mental summary scores and frequency of pain in a month 
are represented as averages.  The standard deviation of the physical and mental quality of life 
measures are 17.686 and 12.8886, respectively.  The standard deviation for the frequency of pain 
per month is 8.9197. 
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 Table 5. Counts of all Covariates by Combined Pain Rank Score 
Pain Index 0 1 2 3 4 5 Blank
Total Count 5 41 24 123 117 26 8 
Males 2 18 16 65 53 12 - 
Females 3 23 8 58 64 14 - 
Familial 5 6 2 18 27 7 8 
Non-
Familial - 35 22 105 90 19 - 
Smokers 4 14 7 58 45 11 6 
Non-
Smokers 1 25 17 64 69 15 2 
Alcoholics 4 30 9 77 72 17 5 
Non-
Alcoholics 1 11 15 45 44 9 3 
Severe Pain - - - - 117 26 - 
Mild-Mod 
Pain 5 41 24 123 - - 8 
PWS 17.689 26.209 37.045 33.814 47.303 -15.84 - 
MWS 17.689 26.209 -5.295 27.757 34.059 -15.84 - 
Pain in 
Months 0 0.333 0 0.833 -3.5 0 - 
 
3.3.5 Correlation of Pain and Quality of Life 
A pairwise correlation study was performed to examine the impact of pain on physical and 
mental quality of life (Table 6). A negative correlation existed between pain and physical weight 
(r = -0.2064), and between pain and mental weight (r = -0.1408). 
 
Table 6. Total Pairwise Correlation of Pain and QOL 
 PAIN PWS MWS 
Pain 1.0000   
PWS -0.2064 1.0000  
MWS -0.1408 0.1569 1.0000 
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 Similarly, correlation studies were also undertaken to determine the relationship between 
pain, quality of life, and environmental factors reported by the patients in the questionnaire 
(Table 7).  Again, pain and quality of life showed a negative correlation.  Pain was also 
negatively correlated with age (r = -0.1055).  A slight negative correlation was found between 
physical quality of life and gender (r = -0.1023), smoking (r = -0.0765), and alcohol use (r = -
0.0768), though these were not significant.  Mental quality of life was also negatively correlated 
with smoking and alcohol use.  
 
Table 7. Total Pairwise Correlation of QOL, Pain, and Covariates 
 Pain Index PWS MWS Age Gender Smoking Alcoholism Familiarity 
Pain 
Duration 
Pain 
Severity
Pain 1.0000          
PWS -0.2134 1.0000         
MWS -0.1461 0.1433 1.0000        
Age -0.1055 0.0035 0.0234 1.0000       
Gender 0.0234 -0.1023 0.0596 
-
0.0811 1.0000      
Smoking 0.0038 -0.0765 
-
0.1251 0.1344 -0.1635 1.0000     
Alcoholism 0.0436 -0.0768 
-
0.1840 0.0643 -0.3194 0.3856 1.0000    
Familiarity -0.0156 
-
0.8990 
-
0.7023 0.0377 -0.1741 0.0083 0.0443 1.000   
Pain 
Duration 0.6211 
-
0.0133 
-
0.0591 
-
0.0927 0.0213 0.0774 0.0755 -0.0549 1.000  
Pain 
Severity 0.775 0.0099 
-
0.0214 
-
0.0674 0.0712 0.0392 0.0047 -0.0979 0.8633 1.000 
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3.4 SPECIFIC AIM 2 
3.4.1 Comparison of Covariates 
All covariates, pain measures, and quality of life scores were compared against each other within 
the total population, familial population, and non-familial population.  These measures were 
compared using box-and-whiskers plots followed by the Mann-Whitney U test giving a p-value.  
For the quality of life measures a student’s t-test for equal variances was used due to the normal 
distribution of the measure.  Table 8 illustrates the p-values for the comparisons within the total 
population. 
 
Table 8. Total Population Comparison of Covariates. 
 PWS MWS Pain Pain Severity
Pain 
Duration 
Pain 
In 
Months 
Familiarity 0.0000 0.0000 0.2440 0.0772 0.4742 0.5578 
Gender 0.0932 0.3115 0.3806 0.2132 0.7428 0.9281 
Diabetes 0.1106 0.2022 0.7787 0.5367 0.3373 0.6696 
Alcoholism 0.8309 0.1934 0.9392 0.9738 0.1847 0.0459 
Smoking 0.6440 0.2934 0.8964 0.5036 0.1759 0.0536 
 
Alcohol and smoking both had an impact on frequency of pain per month. A table 
including the p-values for the quality of life scores and pain scores by severity and duration only 
within the entire population is shown below. 
 
Table 9. Total Population Quality of Life compared with Severity and Duration of Pain 
 PWS MWS 
Pain Severity 0.5059 0.8396 
Pain Duration 0.5745 0.4315 
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 P-values for comparisons between all covariates were also made within the 
subpopulations.  Again, these 2-way comparisons were divided between the environmental 
exposures with pain and quality of life measures (Familial -Table 11; Non-Familial-Table 12) 
and quality of life compared to pain severity and pain duration (Familial-Table 10). 
 
Table 10. Familial Quality of Life compared with Severity and Duration of Pain 
 PWS MWS 
Pain Severity 0.018 0.0194 
Pain Duration 0.0015 0.0141 
 
P-values obtained from the standard t-test with equal variances for comparison of pain 
severity and duration classifications with quality of life showed significant trends within the 
familial population. 
 
Table 11. Non-Familial Quality of Life compared with Severity and Duration of Pain 
 PWS MWS 
Pain Severity 0.6342 0.6344 
Pain Duration 0.8647 0.8665 
 
P-values obtained from the t-test with equal variances for comparison of pain severity and 
duration classifications with quality of life did not show any significant trends within the non-
familial population. 
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Table 12. Familial Comparisons of Covariates 
 Pain PWS MWS Pain Severity
Pain 
Duration 
Pain 
In 
Months 
Gender 0.3802 0.2321 0.6119 0.6039 0.3879 0.5946 
Diabetes 0.5024 0.9815 0.4711 0.5953 0.3680 0.0779 
Alcoholism 0.8043 0.8433 0.1666 0.7915 0.5354 0.5939 
Smoking 0.7121 0.2785 0.0397 0.8602 0.8056 0.1627 
 
A significant trend was seen when smoking and mental qualities of life were compared 
within the familial population. 
 
Table 13. Non-Familial Comparisons of Covariates 
 Pain PWS MWS Pain Severity 
Pain 
Duration 
Pain in 
Months 
Diabetes 0.8830 0.7114 0.7114 0.4495 0.1396 0.6028 
Alcohol 0.9250 0.3048 0.3048 0.8688 0.0704 0.0460 
Smoking 0.7954 0.7601 0.7601 0.3884 0.0999 0.1291 
Gender 0.7386 0.7217 0.7217 0.4103 0.8252 0.7506 
 
Within the non-familial subgroup a significant trend was seen between alcohol use and 
frequency of pain per month. 
3.4.2 Regression with Environmental Covariates 
Regression studies were also performed to examine the relationship between two random 
variables.  Regression analysis was performed on pain and quality of life with multiple variables 
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answered by the study participants.  Five separate regression analyses were performed.  For all 
analyses each alleles for each gene were counted as a variable.  For each allele a mutant allele 
was scored as 1 and a normal allele scored as 0.  For PRSS1 and SPINK1 no heterozygotes exist, 
therefore these allele variables were combined.  Thus, PAR(1) is allele one of the PAR gene and 
PAR(2) is the second allele of the PAR gene, etc. 
 
Table 13. Regression Analysis of Pain Measure and Binary Variables Including Genotype 
Pain 
Measure Coef Std. Err z P>z [95% Conf. Interval] 
Smoking .253957 .2928588 0.87 0.386 (-.3200357, .8279498) 
Alcoholism .3277014 .3096957 1.06 0.290 (-.2792911, .9346938) 
Diabetes -.265623 .31194 -0.85 0.394 (-.8770142, .3457682) 
Familiarity .2336664 .3927836 0.59 0.552 (-.5361753, 1.003508) 
Gender .4104061 .275691 1.49 0.137 (-.1299384, .9507505) 
PAR(1) -.4970362 1.393123 -0.36 0.721 (-3.227508, 2.233435) 
PAR(2) .9454356 .7773508 1.22 0.224 (-.578144, 2.469015) 
SPINK1(1/2) .6658422 .7338226 0.91 0.364 (-.7724236, 2.104108) 
PRSS1(1/2) -2.020095 .846289 -2.39 0.017 (-3.678791, -.3613989) 
 
The first regression (Table 13) used the comprehensive pain measure with all binary variables.  
Alleles one and two of the PRSS1 gene showed a relationship with measure of pain.  The other 
variables did not show a linear relation to pain measure (Table 14). 
 
Table 14. Regression Analysis of Pain Measure and Binary Variables  
Pain 
Measure Coef Std. Err z P>z [95% Conf. Interval] 
Smoking .23006 .2865218 0.80 0.422 (-.3315075, .7916374) 
Alcoholism .0344157 .2953159 0.12 0.907 (-.5443928, .6132241) 
Diabetes -.7028933 .3103272 -2.27 0.024 (-1.311123, .0946631) 
Familiarity .497739 .320971 1.55 0.121 (-.1313526,1.126831) 
Gender -.2707278 .2754921 -.98 0.326 (-.8106823, .2692268) 
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 Table 15. Regression Analysis of Physical Health Score with Binary Variables and Genotype 
PWS COEF. STD ERR. Z P>Z [95% CONF INTERVAL] 
Smoking -1.271828 .8870957 -1.43 0.152 (-3.010503, .4668479) 
Alcoholism .9811537 .9380962 1.05 0.296 (-.8574811, 2.819788) 
Diabetes -.2050867 .9448945 0.828 0.828 (-2.057046, 1.646872) 
Familiarity -41.71774 1.189777 -35.06 0.000 (-44.04966, -39.38582) 
Gender -.4744655 .8350929 -0.57 0.570 (-2.111218, 1.162287) 
PAR(1) 10.43738 4.219896 4.219896 2.47 2.166536, 18.70823 
PAR(2) -8.957851 2.354666 2.354666 -3.80 (-13.57291, -4.342791) 
SPINK1(1/2) -9.201247 2.222815 2.222815 -4.14 (-13.55788, -4.844611) 
PRSS1(1/2) 3.223526 2.563486 2.563486 1.26 (-1.800813, 8.247866) 
 
Table 15 shows a comparison of the binary variables with physical quality of life.  Relationships 
with physical quality of life were seen with heredity as a variable (individuals who report 
familial pancreatitis versus non-familial pancreatitis), the second allele of the PAR gene, and 
both alleles of the SPINK1 gene.  Table 16 shows the same analysis, but without the genotypes to 
limit the number.  Again, familiarity and physical quality of life were extremely related. 
 
Table 16. Regression Analysis of Physical Health Score with Binary Variables 
PWS COEF. STD. ERR. Z P>Z [95% CONF. INTERVAL] 
Smoking -1.131037 .913685 -1.24 0.216 (-2.921827, .6597522) 
Alcoholism .8002285 .9417281 0.85 0.395 (-1.045525, 2.645982) 
Diabetes -.0393467 .9895976 -0.04 0.968 (-1.978922, 1.900229) 
Familiarity -39.16699 1.023539 -38.27 0.000 (-41.17309, -37.16089) 
Gender -.7471892 .8785124 -0.85 0.395 (-2.469042, .9746635) 
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 Table 17. Regression Analysis of Mental Health Score with Binary Variables and Genotype 
MWS COEF. STD. ERR. Z P>Z [95% CONF. INTERVAL] 
Smoking -1.249885 1.049999 -1.19 0.234 (-3.307845, .8080752) 
Alcoholism -.4263546 1.110365 -.38 0.701 (-2.60263, 1.74992) 
Diabetes .0265401 1.118412 0.02 0.981 (-2.165506, 2.218586) 
Familiarity -22.19885 1.408263 -15.76 0.000 (-24.95899, -19.4387) 
Gender .5398056 .9884464 0.55 0.585 (-1.397514, 2.477125) 
PAR(1) -4.777239 4.994822 -0.96 0.339 (-14.56691, 5.012434) 
PAR(2) -4.870557 .7870683 -1.75 0.081 (-10.33311, .5919963) 
SPINK1(1/2) -1.086303 2.631004 -0.41 0.680 (-6.242977, 4.070371) 
PRSS1(1/2) 14.13769 3.034235 4.66 0.000 (8.190702, 20.08469) 
 
Similar to the previous comparison, mental quality of life shows a linear relationship with 
heredity and both alleles of the PRSS1 gene as shown in Table 17.  The regression analysis was 
also performed excluding genotype as a variable (Table 18).  Familiarity and smoking were both 
related to mental health when genotype was not used as a limiting variable.   
 
Table 18. Regression Analysis of Physical Health Scores with Binary Variables   
MWS COEF. STD. ERR. Z P>Z [95% CONF. INTERVAL] 
Smoking -1.826019 1.068309 -1.71 0.087 (-3.919866, .2678284) 
Alcoholism -.4783335 1.101098 -0.43 0.664 (-2.636446, 1.679779) 
Diabetes -.687093 1.157068 -0.59 0.553 (-2.954905, 1.580719) 
Familiarity -22.92194 1.196754 -19.15 0.000 (-25.26754, -20.57635) 
Gender .0041497 1.027184 0.00 0.997 (-2.009094, 2.017394) 
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 Table 19. Regression Analysis of Total QOL Scores with Binary Variables and Genotype 
PWS + 
MWS COEF. STD. ERR. Z P>Z 
[95% CONF 
INTERVAL] 
Smoking -2.476634 1.491082 -1.66 0.097 (-5.399101, .4458334) 
Alcoholism .472683 1.523025 0.31 0.756 (-2.512392, 3.457758) 
Diabetes -.1745279 1.619846 -0.11 0.914 (-3.349368, 3.000312) 
Familiarity -63.92128 2.039314 -31.34 0.000 (-67.91827, -59.9243) 
Gender .0453707 1.426229 0.975 0.434 (-2.749987, 2.840729) 
PAR(1) 5.657721 7.232864 0.78 0.001 (-8.518431, 19.83387) 
PAR(2) -13.82754 4.035857 -3.43 0.007 (-21.73768, -5.917407) 
SPINK(1/2) -10.27499 3.808883 -2.70 0.000 (-17.74026, -2.809717) 
PRSS1(1/2) 17.37376 4.393172 3.95 0.65417 (8.763301, 25.98422) 
 
When physical and mental health scores are combined to give overall quality of life (Table 19) 
multiple variables are related.  Again, relationships between heredity and multiple alleles of 
several genes (PAR and SPINK1) exist.  The same outcome was not observed without genotype 
as a variable. Diabetes showed a strong relationship with total quality of life (Table 20). 
 
Table 20. Regression Analysis of Total Quality of Life Scores with Binary Variables 
PWS + 
MWS COEF. STD. ERR. Z P>Z 
[95% CONF. 
INTERVAL] 
Smoking 2.303185 3.181197 0.72 0.469 ( -3.931846, 8.538217) 
Diabetes 7.301242 3.702236 1.97 0.049 ( .0449924, 14.55749) 
Familiarity -.6722528 3.830624 -0.18 0.861 (-8.180138, 6.835632) 
Gender -.0165831 3.153617 -0.01 0.996 (-6.19755, 6.164392) 
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4.0  DISCUSSION 
4.1 SPECIFIC AIM 1 
Aim:   
 To document the levels of patient reported pain and patient reported quality of life (using 
 the Short Form-12® Quality of Life survey) for individuals with pancreatitis. 
Hypothesis:   
 Patients with Hereditary Pancreatitis will report high levels of chronic pain and poor 
 quality of life in both physical and mental subsets. 
Outcome:   
Patients from the Hereditary Pancreatitis and NAPS2 studies were categorized based on 
multiple demographic variables, level of pain, genotype, and quality of life. 
The majority of subjects in both the familial and non-familial pancreatitis subgroups 
reported severe and constant pain.  When classified according to the combined pain rank 
36.05% of subjects reported constant mild to moderate pain.  Approximately 1/3 (33.7%) 
of patients reported constant mild pain with severe episodes.  Over half of the individuals 
used in this study reported pain levels in these two categories.  Contrary to the original 
hypothesis, this finding shows that all individuals with pancreatitis report a high level of 
pain according to the combined pain rank.  Pain can be described using many facets, and 
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was therefore described based on duration, severity, frequency, and character.  These 
qualities were combined to form the total pain measure, which ranged from -4.04 to 8.69. 
Quality of life measures were described using the SF-12® health survey.  Physical 
summary outcomes ranged from 4.34 to 72.26.  Mental summary scores ranged from       
-11.10 to 58.87.  Scores above 50 represent above average health status. All scores above 
and below 50 are above and below the average for both the physical and mental 
component summaries.  Each one point difference in scores has a direct interpretation; a 
one-point difference is one-tenth of a standard deviation.  Those with a score of 40 
function at a level lower than 84% of the population (one standard deviation). People 
with scores lower than 30 function at a level lower than approximately 98% of the 
population (two standard deviations).  The average physical score was 43.9086, and the 
average mental score was 43.90865.  
Average quality of life indexes for other common diseases are listed in Table 21.46  These 
scores, however, are outcomes from Version 2.0 of the health survey, thus may not 
berepresentative of an exact comparison with Version 1.0 used in this study.  Patients 
with pancreatitis have similar physical health to individuals with stomach ulcers or 
disease.  Physical health is reported to be better than individuals who have cancer, 
diabetes, kidney disease, and congestive heart failure.  The mental health of individuals 
with pancreatitis is comparable to those with anemia.  The only mental health score that 
is lower than that found for pancreatitis is that found for depression.  Therefore, the 
reported mental health of individuals with pancreatitis is lower than that of all the 
surveyed common diseases except one. 
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 Table 21. Quality of Life Indexes for Common Diseases 
CONDITION PHYSICAL SCORE MENTAL SCORE 
“Healthy” Adults 54.41 52.36 
Pancreatitis 43.91 43.91 
Allergies (Chronic) 47.56 47.43 
Anemia 44.25 43.78 
Back Pain/Sciatica 46.10 47.23 
Cancer (Except Skin) 40.93 47.48 
Congestive Heart Failure 40.02 51.15 
Depression 45.77 36.85 
Dermatitis 48.48 47.36 
Diabetes 41.92 48.13 
Hearing Impairment 44.79 48.08 
Heart Disease 39.16 47.00 
Hypertension 44.44 48.95 
Kidney Disease 40.84 44.61 
Liver Disease 39.95 45.44 
Limited Use of Arms/Legs 39.14 46.00 
Lung Disease 38.14 45.59 
Myocardial Infarction 42.34 51.52 
Osteoarthritis/Degenerative 38.70 47.48 
Rheumatoid Arthritis 39.60 46.82 
Ulcer/Stomach Disease 43.09 45.11 
Vision Impairment 44.29 46.42 
 
The advantage of standardizing the SF-12® outcome scores is that each result can be 
compared to the other summary score and have a direct interpretation in relation to the 
distribution scores in the general U.S. population.5 The statistical differences for the SF-
12® analysis were judged significant when p < 0.05.12 A trend was seen when mental and 
physical scores were compared with each other, showing that as one measure increased in 
this population the other measure also increased.  Therefore, for pancreatitis patients 
factors contributing to quality of life have an impact on both physical and mental health.   
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When familiarity was used as a parameter of quality of life, a significant difference was 
evident. As hypothesized, individuals who reported familial pancreatitis reported lower 
physical and mental quality of life than non-familial individuals.  This conclusion was 
supported by a p-value equal to 0.000. 
When the distribution of quality of life scores was compared to pain level, using the 
combined pain rank, a significant trend was noted between certain qualities of pain in 
association with the quality of life measures.  Combined ranks involving more severe 
pain showed poorer overall physical health.  Ranks based on duration, specifically those 
with constant pain, corresponded to lower mental health.  This trend was further 
evaluated and found to be significant when the combined pain rank scores were 
subdivided by these two aspects of pain.  However, this was not a solitary trend. Severe 
pain (instead of mild to moderate pain) showed a significant impact on both physical and 
mental health (p = 0.0007 and p = 0.0194, respectively).  Likewise, constant pain (instead 
of episodic pain) showed a significant impact on both physical and mental health (p = 
0.0007 and p = 0.0141).  
Finally, to document pain and quality of life measures correlation studies were 
performed.  Variables with correlation coefficients, “r”, that were close to 1.0 or –1.0 are 
closely related.  When r is negative, one variable gets larger as the other variable gets 
smaller.  Pain was found to be negatively correlated to both physical and mental health 
scores as was hypothesized.  As pain increased quality of life decreased.  Approximately 
4.26% of the variation in pain is related to the variation in physical health (r = -0.2064).  
A negative correlation was also seen between mental health and pain with an r value 
equal to -0.1023, meaning that 1.98% of the variation in pain is related to the variation in 
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mental health.  Slight negative correlations were also discovered between (a) pain and 
age (r = -0.1055), (b) physical health and gender (r = -0.1023), smoking ( r = -0.0765), 
and alcohol (r = -0.0768), (c) mental health and smoking (r = -0.1251) and alcohol (r = -
0.1840).   
Implications: 
The documentation of the quality of life summary measures and pain levels of patients 
with pancreatitis hopefully provides insight for the implementation of the ultimate goal of 
psychosocial support for individuals with pancreatitis.  Ideally, these measures will be 
used to target individuals who would benefit from additional support.   
In general, hereditary conditions have an earlier age of onset, more severe phenotypic 
effects, and additional mental and psychological factors (such as guilt, fear, and anxiety) 
than their sporadic forms.  The significant difference found between familial and non-
familial subgroups in this study supports this theory, as well as the hypothesis that 
familial individuals report more severe pain and worse quality of life than their 
counterparts.  However, the hereditary component of such conditions typically provides a 
built-in support system in families members who share similar experiences.  These results 
did not support this theory. 
These findings mean that individuals who reported severe and constant pain have lower 
quality of life than those who had mild or moderate pain.  As previously mentioned, the 
majority of the pancreatitis population reported pain levels that were both constant and 
severe to some degree.  The overall quality of life measures also fell below the average of 
the general population.  Within the familial subset of the population the higher level of 
pain had a greater impact on quality of life.  Therefore, these results support the 
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hypothesis that individuals with pancreatitis report a low quality of life and high level of 
pain that may be significant enough to warrant psychosocial intervention. 
In this case, quality of life is a useful tool for identifying patients who are in need of more 
intense support because this population experiences a considerable decline in quality of 
life compared with the general population.  The quality of life health outcome survey 
evaluates emotions and other mental health components that enables researchers to 
understand patient’s perception of health.47  The trends found in the quality of life 
measures obtained from the pancreatitis population suggest a need for more intense 
support.  Although, these findings are only exploratory and need to be repeated in a larger 
sample and in different population. 
 
4.2 SPECIFIC AIM 2 
Aim: 
To explore whether there is a need for a pancreatitis support group. 
Hypothesis: 
Patients with chronic pain attributed to HP would benefit from psychosocial and 
behavioral treatment in the context of a support system. 
Outcome: 
Scores and descriptions of pain and quality of life were compared to each other and a 
series of other variables commonly measured by medical professionals.  Tables of two-
way comparisons show the outcomes of the Mann-Whitney U test and Student’s t-test. 
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Alcohol and smoking were found to have a slight impact on the frequency of severe pain 
episodes per month (p = 0.0459 and p = 0.0536, respectively).  Of more significance, 
when the total population was scored based on familiarity the relation to quality of life 
was evident (p = 0.000).  This finding supports the previous finding that quality of life 
was significantly lower in the familial population than non-familial.  A significant 
relationship was again found between mental health and smoking (p = 0.0397), which 
confirms this finding from the correlation study.   Also supporting the findings of 
correlation studies, physical and mental summary scores were associated with pain 
severity and duration.  This finding was previously reported and described in the first aim 
of the study. 
Regression analysis also further supported the previous findings.  P-values of all relations 
between heredity and pain/quality of life, however combined to form one measure, were 
significant (p = 0.000 for each measure). Of significance, allele variation for each gene 
(genotype) also had an influence on pain and quality of life.  PRSS1 variables influenced 
pain (p = 0.017) and mental health (p = 0.000).  SPINK1 allele variables influenced 
physical health (p = -4.14) and total quality of life (p = 0.000).  Total quality of life and 
physical health by itself were both impacted by mutations in the PAR gene (p = 0.007 
and p = -3.80).   
Implications: 
The findings of the two-way comparisons of all individuals, familial individuals, and 
non-familial individuals and regression analysis confirmed the findings of aim 1.  The 
relationship of pain, quality of life, and genotype confirm the need for additional support 
for these patients. This information may help medical care professionals target 
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individuals who would benefit from additional psychosocial support using commonly 
measured variables.  Again, this was an exploratory study, which needs to be confirmed 
in a larger sample and a different study population. 
Studies have found that chronic pancreatitis and its associated complications have a 
considerable impact on quality of life, but that overall research in this area is insufficient.  
These data are thought to provide insight into the impact of pancreatitis on patient’s 
functional status and well-being.48  According to findings in the literature, little data 
exists documenting whether patients achieve satisfactory quality of life following 
disease-associated complications such as hospital stays.49   Researchers who have 
examined chronic pain and psychological and phenomenological perspectives for dealing 
with pain have found that control and coping contribute to pain.  Individuals that 
experience a lack of control and inefficiently cope with internal and external demands 
have more significant pain.  By identifying individuals with significant pain, medical 
professionals dealing with pancreatitis can identify those individuals that need additional 
assistance in coping with the demands that effect pain.  Programs can be developed to 
promote pain understanding.  After implementation of a pain program, Haugli et. al. 
found a trend towards less pain and a significant effect on how well patients felt they 
were coping with life demands.40 
Studies have also examined the benefit of counseling intervention in addition to general 
medical practice.  Counseling intervention is thought to have a profound effect on mental 
health.50  Therefore, in the pancreatitis population psychological factors are likely linked 
to quality of life in terms of mental health.  Nettleton et. al.  also reported that a great 
need exists to find effective ways of promoting mental health through general practice.44  
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Well-being scores following psychological support showed significant improvement.  
Given these results, the results of this study appear to support the hypothesis that similar 
outcomes following psychological support would be found in the pancreatitis population. 
The effectiveness of support groups has also been investigated and reported in the 
literature.  Most research studies of self-help groups have found important benefits of 
participation.  Chronic illness groups benefited by decreased depression, a more positive 
outlook on life, satisfaction with medical care, and reduced feelings of shame.51  For 
chronic pain specific support groups, participants reported less functional disability as a 
result of participation in a support system. 
 
4.2.1 Patient Interest 
Interest in psychosocial intervention from patients within the Hereditary Pancreatitis population 
has already been shown and verifies the results of this study.  After contact with one patient, the 
desire and need for a support system was evident for this population of individuals who are 
affected with a chronic condition.   
Living with pancreatitis for a lifetime (often without having an official diagnosis for a 
significant portion of that time) can be extremely difficult for patients to the point of being 
devastating.  For this individual, finding others who understood and acknowledged the condition 
was difficult.  Feelings of loneliness and frustration drove her to seek out methods of coping 
beyond traditional medical treatments, though it was difficult to make contacts.  She found the 
lack of information on her condition frustrating, even when researching medical documentation 
and articles.  Having a chronic condition involving unbearable pain was also a significant factor 
in her desire to find support.  She stated that she was not believed when telling others of her 
condition because she looks normal and healthy.  Others do not understand that lethargy is a side 
effect of medications and pain associated with pancreatitis.  For this reason, individuals with 
pancreatitis are often labeled as “lazy.”  This is not uncommon in hereditary conditions, and 
often leads to feeling like others don’t understand or have the knowledge to provide ample 
support.  Therefore, although families are one system of support that individuals with 
pancreatitis can turn to who are knowledgeable about the condition,  they might not be able to 
adequately calm patient’s fears and anxieties. These aspects of disease not only have a role in 
patient’s physical health, but also in their relationships with others and emotional state.  These 
patients have several additional obstacles to overcome on a daily basis as a result of the 
condition. 
As a result of these reasons and feelings, individuals with pancreatitis feel the need to 
seek out others that truly know how they feel and what they deal with.  Having emotional 
support in the context of a support group provides individuals with pancreatitis an outlet and 
someone to talk to.  One patient stated that “having a contact who was my same age, in the same 
stage of life as me, and who understood what I was going through would be so beneficial.”  
Having a psychosocial support system or contact would allow these patients to converse with 
others about the variety of issues that accompany a diagnosis of pancreatitis. 
In addition to the demands and suffering patients personally encounter with pancreatitis, 
having a hereditary condition poses other issues.  Having children is difficult for someone with 
pancreatitis, because of the risk (50%) of passing it on to future generations (with involvement of 
PRSS1).  Individuals who are affected by the condition don’t want their children to suffer in the 
same way.  After living with a chronic condition that changes who a person is, the decision to 
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begin a family is difficult. This situation can be extremely difficult for families, and the 
availability of support to discuss such topics would be beneficial so that others don’t have to go 
through it alone.  
After having a discussion with one driven and proactive hereditary pancreatitis patient, 
the goals of this study were proven to be a necessary component of the multi-disciplinary system 
of care for patients who have pancreatitis. 
 
In summary, as hypothesized, individuals with pancreatitis report a severe and constant 
pain level that negatively influences quality of life.  Given this correlation, participants should 
benefit from intervention in the form of psychosocial support.  Individuals with pancreatitis 
would benefit from discussing with other individuals, gaining knowledge about pancreatitis, 
adapting to life with pain, learning alternative coping strategies, having a sense of belonging, 
making new friendships, and helping others in the process. This study provides information that 
can potentially help health care professionals who work with individuals with pancreatitis and 
who are assessing patient’s quality of life and pain measures as an indicator of who to target for 
psychosocial intervention in addition to general medical practice. 
4.3 LIMITATIONS 
The primary limitation of this study was the generality of the questions elicited from the 
Hereditary Pancreatitis and NAPS2 studies.  The questions used in the SF-12® analysis were 
aimed at global quality of life.  To adapt the quality of life portion of this study to the target 
audience additional questions concerning quality of life could be investigated.   
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Another limitation of this study was the usage of subjects from two different populations.  
Extracting data from both the HP and NAPS2 study allowed for other differences in the study.  
The questionnaires filled out by these two groups were not identical (Appendix D and Appendix 
F).  The slight difference in the wording of the questions presented in each of these 
questionnaires may have prompted slightly different understanding of the questions and in turn 
responses.  Therefore, a potential limitation of this study exists in that individuals might have 
interpreted questions differently.  Also, there are a small number of individuals who are enrolled 
in both the HP and NAPS2 study.  Investigation into whether any of the patients  used in this 
study were actually enrolled into both studies was not performed. 
In regards to the questionnaires, many individuals from the studies did not answer the 
pain and quality of life questions entirely, which reduced the overall sample size used in this 
study.  The sample population (73 individuals) used in this study did not equal the number of 
sporadic pancreatitis patients (271 individuals) obtained from the NAPS2 study.  To increase 
participant numbers, patients could have been contacted through the study site that they were 
enrolled to fill in the information that was missed in the initial completion of the questionnaires.  
Study centers that consistently submitted incomplete questionnaires could also be contacted to 
correct this problem.  In addition, the selection of subjects for this study was limited to 
individuals that responded positively to the question “Does pancreatitis run in your family.”  
This question may have been interpreted incorrectly, or subjects may not have been aware of 
other members in their extended family that have pancreatitis.  Therefore, this discrepancy in 
numbers may have influenced or biased the results obtained in this study. 
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All of the information obtained from the questionnaires was input into the Progeny 
database by hand.  Therefore, another source of error could be in the data entry process when 
transferring responses from paper to computer. 
Lastly, the questions posed in the HP and NAPS2 questionnaires were retrospective.  The 
information obtained for use in this study is all patient report and was not confirmed by medical 
record or physician documentation.  This study required subjects to recollect information and 
feelings about their health.  Individuals may not have accurately reported their pain and quality 
of life over the last several years.  These responses may also be influenced by the patient’s 
current health status.  Therefore, this aspect of the study may be confounded by patient recall 
bias.   
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5.0  FUTURE RESEARCH OPPORTUNITIES 
Given the results of this study, many opportunities for future research exist. It would be useful to 
investigate questions regarding the subject’s current methods of coping with pain.  This would 
provide additional insight into the necessity for and utility of psychosocial intervention.  
Inquiring about subject’s use of alternative pain management techniques would also be 
interesting to assess options outside of medication and psychosocial support as pain intervention.  
In addition, questioning the participant’s current system of support would be important to 
examine.  Support systems already in place would influence the responses to quality of life and 
level of pain obtained in this study.  It would also be useful to look at patient’s response to their 
current employment status as in indicator for how pancreatitis effects a normal aspect of 
everyday life.  Employment status would also give insight as to whether the pain associated with 
pancreatitis is severe enough that affected individuals cannot work at all.  In addition,  how many 
days of work or school the individuals with pancreatitis miss would be useful for assessing their 
quality of life with respect to pain and pancreatitis. 
As the first step in the protocol for organization and initiation of a support system for 
individuals with pancreatitis, an interest survey could be assembled.  A variety of items can be 
addressed in the survey including questions regarding patient satisfaction with information 
provided by their physician, and details surrounding the formation of a support group.  Potential 
participants should be asked whether they felt they were provided with enough medical 
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information at the time of genetic testing or their diagnosis of pancreatitis.  In addition to 
questions concerning medical information, inquiring about satisfaction with the amount of 
information given to them about emotional support options, as well as their interest in speaking 
to other individuals who have pancreatitis, should be a point in the interest survey.   
The interest survey can also obtain opinions of potential participants and topics 
surrounding the details of a support group.  Various systems and organization set-ups exist for 
support groups.  The questionnaire can ask the patient their preference for a face-to-face group 
meeting (at a pancreatitis study site or care center) or an online message board.  Other 
preferences to consider in implementing a support group would include whom to include in the 
group or limit the group to (age, type of pancreatitis, etc.), possible topics of discussion, support 
for family members or support persons in addition and separately from those with a diagnosis of 
pancreatitis, how often the group should meet, the location of the meetings, and what time of day 
(these details would be different according to each center). 
Following the receipt of the interest survey, the information can be compiled and used to 
form a support group or an alternative for psychosocial intervention as well as patient’s interest 
in additional support.  Based on the interest expressed in the survey, study participants could be 
recruited to participate in the study with an explanation of the purpose, and informed consent 
obtained and documented. 
Given the small population of hereditary patients that is spread throughout the country, a 
face-to-face support group would not be feasible.  Support groups for pancreatitis in general 
(hereditary and sporadic) could be formed at study sites or pancreatitis centers.  Alternative 
forms of support can be investigated including a contact list and online message board. 
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Following a predetermined length of time for the intervention in place, a post-support 
questionnaire comprised of questions involving pain and quality of life can be administered to 
compare pre- and post-intervention attitudes.  The benefit of comparing patient’s quality of life 
before and after intervention would allow researchers to assess whether patients were benefiting 
from these services.  This comparison would also confirm the findings of this study, which based 
on patients’ report of pain level and quality of life psychosocial intervention is warranted.  
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APPENDIX A 
TABLES CORRESPONDING TO TEXT 
Table 22. SF-12® Mean Scores- 1990 General Population 
AGE PCS MCS 
45-54 50 50 
55-64 47 51 
65-74 44 52 
>75 39 50 
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APPENDIX B 
FIGURES CORRESPONDING TO TEXT 
 
Figure 22. Trypsin Molecule 
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APPENDIX C 
INFORMED CONSENT FOR NAPS2 STUDY 
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APPENDIX D 
NAPS2 QUESTIONNAIRE 
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APPENDIX E 
INFORMED CONSENT FOR HP STUDY 
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APPENDIX F 
HP QUESTIONNAIRE 
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